Siddharth Sharma (S Sharma)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Topics

Small Cell Lung Cancer

Chronic Obstructive Pulmonary Disease

Patients Undergoing

Top Venues

Journal of biochemical and molecular toxicology

Pharmacogenomics

Future oncology (London, England)

Xenobiotica; the fate of foreign compounds in biological systems

This page only lists publications with an associated author ORCID identifier.

Publications

Anmol Bhatia, Atul Kumar Upadhyay, Siddharth Sharma
Screening and analysis of single nucleotide polymorphism in the 3'-UTR microRNA target regions and its implications for lung tumorigenesis. Pharmacogenomics (2024)
Depanshi Pandit, Parul Sharma, Harsh Yadav, Kranti Garg, Vishal Chopra, Siddharth Sharma
Association of IL4RA polymorphism in predicting susceptibility toward chronic obstructive pulmonary disease. Pharmacogenomics (2023)
Harsh Yadav, Deepanshi Pandit, Sidhartha Singh, Parul Sharma, Kranti Garg, Nidhi Girdhar, Karan Sharma, Vishal Chopra, Siddharth Chopra, Siddharth Sharma
GST polymorphism as a predictive biomarker for modulating the susceptibility to chronic obstructive pulmonary disease: A North Indian study. Experimental physiology (2023)
Sidhartha Singh, Navneet Singh, Siddharth Sharma
Genetic polymorphisms in the mismatch repair pathway (MMR) genes contribute to hematological and gastrointestinal toxicity in North Indian lung cancer patients treated with platinum-based chemotherapy. Journal of biochemical and molecular toxicology 36 (11) (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology 37 (3) (2022)
Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma
Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective. Current treatment options in oncology 23 (2) (2022)
Sidhartha Singh, Navneet Singh, Manoj Baranwal, Siddharth Sharma
Polymorphisms in the MSH2 gene predict poor survival of North Indian lung cancer patients undergoing chemotherapy. Biomarkers in medicine (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology 37 (3) (2022)
Anmol Bhatia, Atul Kumar Upadhyay, Siddharth Sharma
miRNAs are now starring in "No Time to Die: Overcoming the chemoresistance in cancer". IUBMB life (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
Polymorphisms in solute carrier genes (SLC19A1, SLCO1B1, and SLCO1B3) predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of clinical pharmacy and therapeutics (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology 37 (3) (2022)
Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma
Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. International journal of environmental health research (2022)
Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma
Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy. Xenobiotica; the fate of foreign compounds in biological systems 52 (3) (2022)
Parul Sharma, Navneet Singh, Siddharth Sharma
ATP binding cassette transporters and cancer: revisiting their controversial role. Pharmacogenomics 22 (18) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
GSTP1 Ile105Val polymorphism among North Indian lung cancer patients treated using monotherapy and poly-pharmacy. Human & experimental toxicology 40 (12_suppl) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients. Journal of chemotherapy (Florence, Italy) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
Association of NAT-2 gene polymorphisms toward lung cancer susceptibility and prognosis in North Indian patients treated with platinum-based chemotherapy. Pharmacogenomics 23 (2) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
Genetic polymorphisms in the mEH gene in relation to tobacco smoking: role in lung cancer susceptibility and survival in north Indian patients with lung cancer undergoing platinum-based chemotherapy. Future oncology (London, England) 17 (35) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Personalized medicine 18 (4) (2021)
Harleen Kaur Walia, Navneet Singh, Siddharth Sharma
Genetic polymorphism of Arg213His variant in the SULT1A1 gene is associated with reduced susceptibility to lung cancer in North Indian population. Xenobiotica; the fate of foreign compounds in biological systems 51 (9) (2021)
H K Walia, U Verma, Navneet Singh, Siddharth Sharma
Polymorphisms in GSTM1 and GSTT1 influence the response and treatment outcome in lung cancer patients treated with platinum-based chemotherapy. British journal of biomedical science 76 (4) (2019)
Amrita Singh, Navneet Singh, Digambar Behera, Siddharth Sharma
XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genes. Future oncology (London, England) 15 (33) (2019)
Shweta Lawania, Navneet Singh, Digambar Behera, Siddharth Sharma
Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North Indians. Biochemical genetics 56 (4) (2018)
Amrita Singh, Navneet Singh, Digambar Behera, Siddharth Sharma
Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy. Molecular biology reports 45 (3) (2018)
Amrita Singh, Navneet Singh, Digambar Behera, Siddharth Sharma
Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy. Pathology oncology research : POR 25 (4) (2017)